| 1. |
Dai Y, Zhu L, Zhou Y, et al. Incidence of retinopathy of prematurity treatment in extremely preterm infants in China[J]. Paediatr Perinat Epidemiol, 2022, 36(3): 380-389. DOI: 10.1111/ppe.12810.
|
| 2. |
Goldstein GP, Leonard SA, Kan P, et al. Prenatal and postnatal inflammation-related risk factors for retinopathy of prematurity[J]. J Perinatol, 2019, 39(7): 964-973. DOI: 10.1038/s41372-019-0357-2.
|
| 3. |
Cupp MA, Cariolou M, Tzoulaki I, et al. Neutrophil to lymphocyte ratio and cancer prognosis: an umbrella review of systematic reviews and meta-analyses of observational studies[J/OL]. BMC Med, 2020, 18(1): 360[2020-11-20]. https://pubmed.ncbi.nlm.nih.gov/33213430/. DOI:10.1186/s12916-020-01817-1.
|
| 4. |
Wang JR, Chen Z, Yang K, et al. Association between neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and diabetic retinopathy among diabetic patients without a related family history[J/OL]. Diabetol Metab Syndr, 2020, 12: 55[2020-07-02]. https://pubmed.ncbi.nlm.nih.gov/32636938/. DOI: 10.1186/s13098-020-00562-y.
|
| 5. |
Akdogan M, Ustundag Y, Cevik SG, et al. Correlation between systemic immune-inflammation index and routine hemogram-related inflammatory markers in the prognosis of retinopathy of prematurity[J]. Indian J Ophthalmol, 2021, 69(8): 2182-2187. DOI: 10.4103/ijo.IJO_2745_20.
|
| 6. |
Parrozzani R, Nacci EB, Bini S, et al. Severe retinopathy of prematurity is associated with early post-natal low platelet count[J/OL]. Sci Rep, 2021, 11(1): 891[2021-01-13]. https://pubmed.ncbi.nlm.nih.gov/33441659/. DOI: 10.1038/s41598-020-79535-0.
|
| 7. |
Oruz O, Dervi?o?ullar? MS, ?ktem ME, et al. Predictive role of systemic immune-inflammation index and neutrophil/lymphocyte ratio values in infants with retinopathy of prematurity[J]. Graefe's Arch Clin Exp Ophthalmol, 2024, 262(10): 3125-3134. DOI: 10.1007/s00417-024-06493-y.
|
| 8. |
中華醫學會眼科學分會眼底病學組. 中國早產兒視網膜病變篩查指南(2014年)[J]. 中華眼科雜志, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.Fundus Disease Group of Ophthalmology Branch of Chinese Medical Association. Guidelines for screening retinopathy of prematurity in Chinese infants (2014)[J]. Chin J Ophthalmol, 2014, 50(12): 933-935. DOI: 10.3760/cma.j.issn.0412-4081.2014.12.017.
|
| 9. |
中華醫學會眼科學分會眼底病學組, 中國醫師協會眼科醫師分會眼底病專委會. 中國早產兒視網膜病變分類和治療專家共識(2023年)[J]. 中華眼底病雜志, 2023, 39(9): 720-727. DOI: 10.3760/cma.j.cn511434-20230815-00346.Retinal Disease Group of Ophthalmology Branch, Chinese Medical Association, Fundus Disease Specialized Committee of Ophthalmology Branch, Chinese Medical Doctor Association. Expert consensus on the classification and treatment of retinopathy of prematurity in China (2023 edition)[J]. Chin J Ocul Fundus Dis, 2023, 39(9): 720-727. DOI: 10.3760/cma.j.cn511434-20230815-00346.
|
| 10. |
Fevereiro-Martins M, Marques-Neves C, Guimar?es H, et al. Retinopathy of prematurity: a review of pathophysiology and signaling pathways[J]. Surv Ophthalmol, 2023, 68(2): 175-210. DOI: 10.1016/j.survophthal.2022.11.007.
|
| 11. |
Yucel OE, Eraydin B, Niyaz L, et al. Incidence and risk factors for retinopathy of prematurity in premature, extremely low birth weight and extremely low gestational age infants[J/OL]. BMC Ophthalmol, 2022, 22(1): 367[2022-09-13]. https://pubmed.ncbi.nlm.nih.gov/36096834/. DOI: 10.1186/s12886-022-02591-9.
|
| 12. |
Yu CW, Popovic MM, Dhoot AS, et al. Demographic risk factors of retinopathy of prematurity: a systematic review of population-based studies[J]. Neonatology, 2022, 119(2): 151-163. DOI: 10.1159/000519635.
|
| 13. |
Ingvaldsen SH, Morken TS, Austeng D, et al. Visuopathy of prematurity: is retinopathy just the tip of the iceberg?[J]. Pediatr Res, 2022, 91(5): 1043-1048. DOI: 10.1038/s41390-021-01625-0.
|
| 14. |
Humberg A, Fortmann I, Siller B, et al. Preterm birth and sustained inflammation: consequences for the neonate[J]. Semin Immunopathol, 2020, 42(4): 451-468. DOI: 10.1007/s00281-020-00803-2.
|
| 15. |
Obata S, Matsumoto R, Kakinoki M, et al. Blood neutrophil-to-lymphocyte ratio as a risk factor in treatment for retinopathy of prematurity[J]. Graefe's Arch Clin Exp Ophthalmol, 2023, 261(4): 951-957. DOI: 10.1007/s00417-022-05902-4.
|
| 16. |
Anderson J, Thang CM, Thanh LQ, et al. Immune profiling of cord blood from preterm and term infants reveals distinct differences in pro-inflammatory responses[J/OL]. Front Immunol, 2021, 12: 777927[2021-11-01]. https://pubmed.ncbi.nlm.nih.gov/34790206/. DOI: 10.3389/fimmu.2021.777927.
|
| 17. |
Joelsson JP, Asbjarnarson A, Sigurdsson S, et al. Ventilator-induced lung injury results in oxidative stress response and mitochondrial swelling in a mouse model[J/OL]. Lab Anim Res, 2022, 38(1): 23[2022-07-22]. https://pubmed.ncbi.nlm.nih.gov/35869495/. DOI: 10.1186/s42826-022-00133-4.
|
| 18. |
Goldstein JA, Gallagher K, Beck C, et al. Maternal-fetal inflammation in the placenta and the developmental origins of health and disease[J/OL]. Front Immunol, 2020, 11: 531543[2020-11-13]. https://pubmed.ncbi.nlm.nih.gov/33281808/. DOI:10.3389/fimmu.2020.531543.
|
| 19. |
Sun Z, He L, Zhao C, et al. The effect of leucocytosis on retinopathy of prematurity[J/OL]. Sci Rep, 2023, 13(1): 20414[2023-11-21]. https://pubmed.ncbi.nlm.nih.gov/37989837/. DOI: 10.1038/s41598-023-47298-z.
|
| 20. |
Vinekar A, Nair AP, Sinha S, et al. Tear fluid angiogenic factors: potential noninvasive biomarkers for retinopathy of prematurity screening in preterm infants[J/OL]. Invest Ophthalmol Vis Sci, 2021, 62(3): 2[2021-03-01]. https://pubmed.ncbi.nlm.nih.gov/33646290/. DOI: 10.1167/iovs.62.3.2.
|
| 21. |
K?ran Yenice E, Kara C, Karsli Türkoglu T, et al. Predictive value of serum inflammatory markers in retinopathy of prematurity[J]. Eye (Lond), 2024, 38(14): 2822-2826. DOI: 10.1038/s41433-024-03260-5.
|
| 22. |
Sood BG, Madan A, Saha S, et al. Perinatal systemic inflammatory response syndrome and retinopathy of prematurity[J]. Pediatr Res, 2010, 67(4): 394-400. DOI: 10.1203/PDR.0b013e3181d01a36.
|
| 23. |
Brown JVE, Meader N, Wright K, et al. Assessment of C-reactive protein diagnostic test accuracy for late-onset infection in newborn infants: a systematic review and meta-analysis[J]. JAMA Pediatr, 2020, 174(3): 260-268. DOI: 10.1001/jamapediatrics.2019.5669.
|
| 24. |
楊春燕, 楊玉軍, 李寶云, 等. 超敏C-反應蛋白與白蛋白比值對早產兒早發型感染的診斷價值[J]. 中華危重病急救醫學, 2016, 28(2): 173-177. DOI: 10.3760/cma.j.issn.2095-4352.2016.02.017.Yang CY, Yang YJ, Li BY, et al. Diagnostic value of high-sensitivity C-reactive protein to albumin ratio in early-onset infections in preterm infants[J]. Chin J Crit Care Med, 2016, 28(2): 173-177. DOI: 10.3760/cma.j.issn.2095-4352.2016.02.017.
|
| 25. |
Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives[J]. Bratisl Lek Listy, 2021, 122(7): 474-488. DOI: 10.4149/BLL_2021_078.
|
| 26. |
Rehman FU, Khan A, Aziz A, et al. Neutrophils to lymphocyte ratio: earliest and efficacious markers of sepsis[J/OL]. Cureus, 2020, 12(10): e10851[2020-10-08]. https://pubmed.ncbi.nlm.nih.gov/33178505/. DOI: 10.7759/cureus.10851.
|
| 27. |
Cao L, Liu X, Sun T, et al. Predictive and diagnostic values of systemic inflammatory indices in bronchopulmonary dysplasia[J/OL]. Children (Basel), 2023, 11(1): 24[2023-12-25]. https://pubmed.ncbi.nlm.nih.gov/38255338/. DOI: 10.3390/children11010024.
|
| 28. |
Parrozzani R, Marchione G, Fantin A, et al. Thrombocytopenia as type 1 ROP biomarker: a longitudinal study[J/OL]. J Pers Med, 2021, 11(11): 1120[2021-10-30]. https://pubmed.ncbi.nlm.nih.gov/34834472/. DOI:10.3390/jpm11111120.
|
| 29. |
Islam MM, Satici MO, Eroglu SE. Unraveling the clinical significance and prognostic value of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, systemic immune-inflammation index, systemic inflammation response index, and delta neutrophil index: an extensive literature review[J]. Turk J Emerg Med, 2024, 24(1): 8-19. DOI: 10.4103/tjem.tjem_198_23.
|